Subtype
Colorectal Neoplasm
CI-CAN-00002404Explore in graph →
Non-malignant1,784 active trials21 approved drugs382 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002404Explore in graph →
Clinical trials
8,604 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01340508 | Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | Apr 22, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00166465 | Stage IV Colorectal CA ALIMTA | completed | Phase 1 / Phase 2 | 200 | Mayo ClinicOTHER | 1 | Mar 14, 2011 | clinicaltrials |
| NCT01305980 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00044863 | Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma | completed | Phase 2 | 250 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00224601 | CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT01157806 | Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases | unknown | Phase 2 | 20 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT00232453 | Preoperative Combined Radiation and Chemotherapy - Rectal Cancer | completed | Phase 2 | 34 | University Health Network, TorontoOTHER | 1 | Feb 15, 2011 | clinicaltrials |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00233623 | Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | withdrawn | Phase 2 | 190 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | terminated | Phase 2 | 180 | AstraZenecaINDUSTRY | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00113776 | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00784667 | Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib(Dux) | unknown | Phase 2 | 50 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01249521 | Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer(Vengeance) | unknown | Phase 2 | 40 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01144195 | A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy(ACTIVE) | unknown | Phase 2 | 80 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00254137 | Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 92 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT01212718 | Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase(FOGT5) | completed | Phase 2 | 168 | University of UlmOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00839111 | Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | unknown | Phase 2 | 43 | Fudan UniversityOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT00102024 | Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma | terminated | Phase 1 / Phase 2 | 30 | BiogenINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00106054 | Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases | terminated | Phase 2 | 2 | PfizerINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00403624 | Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer | completed | Phase 1 / Phase 2 | 38 | SanofiINDUSTRY | 0 | Aug 27, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00188565 | Celebrex With Preoperative Chemoradiation - Rectal Cancer | completed | Phase 1 / Phase 2 | 39 | University Health Network, TorontoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT01152710 | Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer | completed | Phase 2 | 57 | Institute of Oncology LjubljanaOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00172159 | Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers | unknown | Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Jun 23, 2010 | clinicaltrials |
| NCT01142713 | The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study | unknown | Phase 2 | 30 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005981 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00671996 | Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C(MANFOL) | completed | Phase 2 | 14 | Egetis TherapeuticsINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT00055419 | A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer | completed | Phase 2 | 744 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT01024504 | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Apr 9, 2010 | clinicaltrials |
| NCT01086683 | Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course | completed | Phase 2 / Phase 3 | 513 | Danish Cancer SocietyOTHER | 1 | Mar 15, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00277303 | Study of XL999 in Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 17 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 22, 2010 | clinicaltrials |
| NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 / Phase 3 | 600 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00251186 | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients | terminated | Phase 2 | 18 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | completed | Phase 1 / Phase 2 | 38 | PhotocureINDUSTRY | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer(EXPERT-C) | unknown | Phase 2 | 164 | Royal Marsden NHS Foundation TrustOTHER | 3 | Jan 13, 2010 | clinicaltrials |
| NCT00220116 | Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer | completed | Phase 2 | 172 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Apr 22, 2011source: clinicaltrials